RU2121830C1
(ru)
*
|
1992-09-18 |
1998-11-20 |
Яманоути Фармасьютикал Ко., ЛТД |
Гидрогелевый препарат с длительным высвобождением лекарства
|
DE19509807A1
(de)
*
|
1995-03-21 |
1996-09-26 |
Basf Ag |
Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
|
US5945125A
(en)
*
|
1995-02-28 |
1999-08-31 |
Temple University |
Controlled release tablet
|
US6166024A
(en)
*
|
1995-03-30 |
2000-12-26 |
Mayo Foundation For Medical Education And Research |
Use of topical azathioprine and thioguanine to treat colorectal adenomas
|
EP0761209A3
(en)
*
|
1995-09-01 |
1998-02-04 |
J.B. Chemicals & Pharmaceuticals Ltd. |
Controlled release formulations of ranitidine
|
ES2325046T3
(es)
*
|
1996-06-26 |
2009-08-24 |
The Board Of Regents, The University Of Texas System |
Formulacion farmaceutica extruible por fusion en caliente.
|
WO1998002182A1
(en)
*
|
1996-07-12 |
1998-01-22 |
Novartis Consumer Health S.A. |
Oral pharmaceutical combinations of nsaids with terpenoids
|
GB9720797D0
(en)
*
|
1997-09-30 |
1997-12-03 |
Rhodes John |
Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
|
US20040029962A1
(en)
*
|
1997-12-12 |
2004-02-12 |
Chih-Ming Chen |
HMG-COA reductase inhibitor extended release formulation
|
US20060141036A1
(en)
*
|
1997-12-12 |
2006-06-29 |
Andrx Labs Llc |
HMG-CoA reductase inhibitor extended release formulation
|
SE9704869D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulaton II
|
DE19901040A1
(de)
*
|
1999-01-14 |
2000-07-20 |
Knoll Ag |
Arzneiformen mit gesteuerter Freisetzung, enthaltend gut wasserlösliche Wirkstoffe
|
EG23951A
(en)
|
1999-03-25 |
2008-01-29 |
Otsuka Pharma Co Ltd |
Cilostazol preparation
|
CA2372994C
(en)
*
|
1999-06-04 |
2010-03-23 |
Alza Corporation |
Implantable gel compositions and method of manufacture
|
US6562375B1
(en)
|
1999-08-04 |
2003-05-13 |
Yamanouchi Pharmaceuticals, Co., Ltd. |
Stable pharmaceutical composition for oral use
|
CA2395333C
(en)
*
|
1999-12-23 |
2009-01-13 |
Pfizer Products Inc. |
Hydrogel-driven drug dosage form
|
US20020028240A1
(en)
*
|
2000-04-17 |
2002-03-07 |
Toyohiro Sawada |
Timed-release compression-coated solid composition for oral administration
|
AU2001250646A1
(en)
*
|
2000-04-17 |
2001-10-30 |
Yamanouchi Pharmaceutical Co..Ltd. |
Drug delivery system for avoiding pharmacokinetic interaction between drugs and method thereof
|
US6419954B1
(en)
*
|
2000-05-19 |
2002-07-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Tablets and methods for modified release of hydrophilic and other active agents
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
PE20030527A1
(es)
*
|
2001-10-24 |
2003-07-26 |
Gruenenthal Chemie |
Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
|
US20030152622A1
(en)
*
|
2001-10-25 |
2003-08-14 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral diuretic
|
US20030091630A1
(en)
*
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
RU2322263C2
(ru)
*
|
2001-11-13 |
2008-04-20 |
Астеллас Фарма, Инк. |
Система продолжительного высвобождения растворимого лекарственного средства
|
ATE395044T1
(de)
*
|
2002-02-01 |
2008-05-15 |
Pfizer Prod Inc |
Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
|
WO2003072085A1
(fr)
*
|
2002-02-27 |
2003-09-04 |
Shionogi & Co., Ltd. |
Preparations solides contenant un medicament a peine soluble dans l'eau d'une meilleure absorbabilite
|
NZ519363A
(en)
*
|
2002-06-05 |
2004-02-27 |
Agres Ltd |
A novel drug dosing regimen
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
PA8578501A1
(es)
|
2002-07-25 |
2005-02-04 |
Pharmacia Corp |
Forma de dosificacion una vez al dia de pramipexol
|
AU2003262059A1
(en)
|
2002-09-11 |
2004-04-30 |
Takeda Pharmaceutical Company Limited |
Sustained release preparation
|
MY148805A
(en)
*
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
JP4459543B2
(ja)
*
|
2003-03-17 |
2010-04-28 |
株式会社メドジェル |
徐放性ハイドロゲル製剤
|
JP2007501218A
(ja)
|
2003-08-04 |
2007-01-25 |
ファイザー・プロダクツ・インク |
非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
DE102005005446A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
US8128958B2
(en)
|
2003-11-10 |
2012-03-06 |
Astellas Pharma Inc. |
Sustained release pharmaceutical composition
|
US8197846B2
(en)
|
2003-11-10 |
2012-06-12 |
Astellas Pharma Inc. |
Sustained release pharmaceutical composition
|
US20050171248A1
(en)
*
|
2004-02-02 |
2005-08-04 |
Yanmei Li |
Hydrogel for use in downhole seal applications
|
EP1750717B1
(en)
*
|
2004-02-11 |
2017-07-19 |
Rubicon Research Private Limited |
Controlled release pharmaceutical compositions with improved bioavailability
|
HUE037643T2
(hu)
|
2004-06-12 |
2018-09-28 |
Collegium Pharmaceutical Inc |
Visszaélésre nem alkalmas gyógyszerkészítmények
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
WO2006015277A1
(en)
*
|
2004-07-30 |
2006-02-09 |
Baker Hughes Incorporated |
Downhole inflow control device with shut-off feature
|
SG164375A1
(en)
|
2004-08-13 |
2010-09-29 |
Boehringer Ingelheim Int |
Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
|
EA201001083A1
(ru)
|
2004-08-13 |
2011-08-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Композиция таблетки пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
|
US20060074182A1
(en)
|
2004-09-30 |
2006-04-06 |
Depuy Products, Inc. |
Hydrogel composition and methods for making the same
|
RU2007116944A
(ru)
*
|
2004-10-05 |
2008-11-20 |
Астеллас Фарма Инк. (Jp) |
Фармацевтическая композиция для лечения высыхания слезной и слюнной жидкости
|
JP2008523143A
(ja)
*
|
2004-12-13 |
2008-07-03 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
月経困難症の治療のためのα−アドレナリン遮断剤の使用
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US20060239956A1
(en)
*
|
2005-04-26 |
2006-10-26 |
Lulu Henson |
Preparation and use of hydrogels
|
CN101277699B
(zh)
*
|
2005-08-23 |
2011-01-12 |
日产化学工业株式会社 |
缓释制剂
|
CN101304764B
(zh)
*
|
2005-11-11 |
2012-12-05 |
旭化成化学株式会社 |
控释固体制剂
|
GB0607534D0
(en)
*
|
2006-04-13 |
2006-05-24 |
Univ London Pharmacy |
Colonic drug delivery formulation
|
WO2007131804A1
(en)
|
2006-05-17 |
2007-11-22 |
Synthon B.V. |
Tablet composition with a prolonged release of tamsulosin
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
CA2669324C
(en)
|
2006-11-13 |
2012-06-19 |
Kyorin Pharmaceutical Co., Ltd. |
Method for preparing sustained release tablet
|
US20080221047A1
(en)
|
2006-12-27 |
2008-09-11 |
Astellas Pharma Inc., |
Aminoakyl methacrylate copolymer E for maintaining solubility of poorly-soluble drug
|
KR100885029B1
(ko)
*
|
2007-02-07 |
2009-02-23 |
지엘팜텍 주식회사 |
경구투여용 서방성 삼중정제
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
US20090036414A1
(en)
*
|
2007-08-02 |
2009-02-05 |
Mutual Pharmaceutical Company, Inc. |
Mesalamine Formulations
|
EP2047847A1
(en)
|
2007-10-12 |
2009-04-15 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Solid pharmaceutical composition comprising tamsulosin
|
US7942206B2
(en)
|
2007-10-12 |
2011-05-17 |
Baker Hughes Incorporated |
In-flow control device utilizing a water sensitive media
|
US8312931B2
(en)
|
2007-10-12 |
2012-11-20 |
Baker Hughes Incorporated |
Flow restriction device
|
US8096351B2
(en)
*
|
2007-10-19 |
2012-01-17 |
Baker Hughes Incorporated |
Water sensing adaptable in-flow control device and method of use
|
US7891430B2
(en)
|
2007-10-19 |
2011-02-22 |
Baker Hughes Incorporated |
Water control device using electromagnetics
|
US7775277B2
(en)
*
|
2007-10-19 |
2010-08-17 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US7913755B2
(en)
|
2007-10-19 |
2011-03-29 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US7784543B2
(en)
*
|
2007-10-19 |
2010-08-31 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US8069921B2
(en)
*
|
2007-10-19 |
2011-12-06 |
Baker Hughes Incorporated |
Adjustable flow control devices for use in hydrocarbon production
|
US8544548B2
(en)
*
|
2007-10-19 |
2013-10-01 |
Baker Hughes Incorporated |
Water dissolvable materials for activating inflow control devices that control flow of subsurface fluids
|
US7918272B2
(en)
*
|
2007-10-19 |
2011-04-05 |
Baker Hughes Incorporated |
Permeable medium flow control devices for use in hydrocarbon production
|
US7913765B2
(en)
*
|
2007-10-19 |
2011-03-29 |
Baker Hughes Incorporated |
Water absorbing or dissolving materials used as an in-flow control device and method of use
|
US7775271B2
(en)
|
2007-10-19 |
2010-08-17 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US20090101354A1
(en)
*
|
2007-10-19 |
2009-04-23 |
Baker Hughes Incorporated |
Water Sensing Devices and Methods Utilizing Same to Control Flow of Subsurface Fluids
|
US7789139B2
(en)
|
2007-10-19 |
2010-09-07 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US7793714B2
(en)
|
2007-10-19 |
2010-09-14 |
Baker Hughes Incorporated |
Device and system for well completion and control and method for completing and controlling a well
|
US20090101344A1
(en)
*
|
2007-10-22 |
2009-04-23 |
Baker Hughes Incorporated |
Water Dissolvable Released Material Used as Inflow Control Device
|
US7918275B2
(en)
*
|
2007-11-27 |
2011-04-05 |
Baker Hughes Incorporated |
Water sensitive adaptive inflow control using couette flow to actuate a valve
|
BRPI0906467C1
(pt)
|
2008-01-25 |
2021-05-25 |
Gruenenthal Gmbh |
forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
|
US7597150B2
(en)
|
2008-02-01 |
2009-10-06 |
Baker Hughes Incorporated |
Water sensitive adaptive inflow control using cavitations to actuate a valve
|
US8839849B2
(en)
*
|
2008-03-18 |
2014-09-23 |
Baker Hughes Incorporated |
Water sensitive variable counterweight device driven by osmosis
|
US7992637B2
(en)
*
|
2008-04-02 |
2011-08-09 |
Baker Hughes Incorporated |
Reverse flow in-flow control device
|
DE102008022520A1
(de)
*
|
2008-05-07 |
2009-11-12 |
Bayer Animal Health Gmbh |
Feste Arzneimittelformulierung mit verzögerter Freisetzung
|
US8931570B2
(en)
*
|
2008-05-08 |
2015-01-13 |
Baker Hughes Incorporated |
Reactive in-flow control device for subterranean wellbores
|
LT2273983T
(lt)
|
2008-05-09 |
2016-10-25 |
Grünenthal GmbH |
Tarpinės miltelių kompozicijos gamybos būdas ir galutinė kieta dozavimo forma naudojant purškalo kietinimo stadija
|
US8113292B2
(en)
|
2008-05-13 |
2012-02-14 |
Baker Hughes Incorporated |
Strokable liner hanger and method
|
US8171999B2
(en)
*
|
2008-05-13 |
2012-05-08 |
Baker Huges Incorporated |
Downhole flow control device and method
|
US7789152B2
(en)
|
2008-05-13 |
2010-09-07 |
Baker Hughes Incorporated |
Plug protection system and method
|
US7762341B2
(en)
*
|
2008-05-13 |
2010-07-27 |
Baker Hughes Incorporated |
Flow control device utilizing a reactive media
|
US8555958B2
(en)
|
2008-05-13 |
2013-10-15 |
Baker Hughes Incorporated |
Pipeless steam assisted gravity drainage system and method
|
EP2161019A1
(en)
|
2008-09-05 |
2010-03-10 |
KRKA, D.D., Novo Mesto |
Prolonged release multiparticulate pharmaceutical composition comprising paliperidone
|
TWI478712B
(zh)
*
|
2008-09-30 |
2015-04-01 |
Astellas Pharma Inc |
釋控性醫藥組成物
|
US8465770B2
(en)
*
|
2008-12-24 |
2013-06-18 |
Synthon Bv |
Low dose controlled release tablet
|
DK2394648T3
(en)
*
|
2009-02-04 |
2016-09-26 |
Astellas Pharma Inc |
A pharmaceutical composition for oral administration
|
EP2255793A1
(en)
|
2009-05-28 |
2010-12-01 |
Krka Tovarna Zdravil, D.D., Novo Mesto |
Pharmaceutical composition comprising tamsulosin
|
US8056627B2
(en)
*
|
2009-06-02 |
2011-11-15 |
Baker Hughes Incorporated |
Permeability flow balancing within integral screen joints and method
|
US20100300675A1
(en)
*
|
2009-06-02 |
2010-12-02 |
Baker Hughes Incorporated |
Permeability flow balancing within integral screen joints
|
US8151881B2
(en)
*
|
2009-06-02 |
2012-04-10 |
Baker Hughes Incorporated |
Permeability flow balancing within integral screen joints
|
US8132624B2
(en)
*
|
2009-06-02 |
2012-03-13 |
Baker Hughes Incorporated |
Permeability flow balancing within integral screen joints and method
|
US20100300674A1
(en)
*
|
2009-06-02 |
2010-12-02 |
Baker Hughes Incorporated |
Permeability flow balancing within integral screen joints
|
TW201105316A
(en)
|
2009-07-22 |
2011-02-16 |
Gruenenthal Gmbh |
Hot-melt extruded pharmaceutical dosage form
|
KR101747156B1
(ko)
|
2009-07-22 |
2017-06-27 |
그뤼넨탈 게엠베하 |
산화-안정화된 탬퍼-내성 용량형
|
US8795727B2
(en)
|
2009-11-09 |
2014-08-05 |
Spotlight Technology Partners Llc |
Fragmented hydrogels
|
EP2498763A4
(en)
|
2009-11-09 |
2015-10-07 |
Spotlight Technology Partners Llc |
HYDROGELS BASED ON POLYSACCHARIDE
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
CN102821757B
(zh)
|
2010-02-03 |
2016-01-20 |
格吕伦塔尔有限公司 |
通过挤出机制备粉末状药物组合物
|
AU2011219452B2
(en)
*
|
2010-02-24 |
2014-05-29 |
Zoetis Llc |
Veterinary compositions
|
JP5849947B2
(ja)
*
|
2010-03-29 |
2016-02-03 |
アステラス製薬株式会社 |
放出制御医薬組成物
|
JP5849946B2
(ja)
*
|
2010-03-29 |
2016-02-03 |
アステラス製薬株式会社 |
放出制御医薬組成物
|
MX2013002377A
(es)
|
2010-09-02 |
2013-04-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a manipulacion que comprende una sal inorganica.
|
RU2607499C2
(ru)
|
2010-09-02 |
2017-01-10 |
Грюненталь Гмбх |
Устойчивая к разрушению лекарственная форма, которая содержит анионный полимер
|
US9011912B2
(en)
|
2010-10-07 |
2015-04-21 |
Abon Pharmaceuticals, Llc |
Extended-release oral dosage forms for poorly soluble amine drugs
|
DK2826467T3
(en)
|
2010-12-22 |
2017-10-16 |
Purdue Pharma Lp |
INCLUDED, MANIPULATION-PROPOSED SLOW-DELIVERY DOSAGE FORMS
|
CN107412173A
(zh)
|
2010-12-23 |
2017-12-01 |
普渡制药公司 |
抗篡改固体口服剂型
|
KR102027912B1
(ko)
|
2011-02-15 |
2019-10-02 |
지엘팜텍주식회사 |
경구투여용 탐술로신 또는 이의 약제학적으로 허용되는 염을 포함하는 서방성 삼중정제
|
RU2451680C1
(ru)
|
2011-02-21 |
2012-05-27 |
Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм" |
Клатратный комплекс циклодекстрина или арабиногалактана с 9-фенил-симм-октагидроселеноксантеном, способ его получения (варианты), фармацевтическая композиция и лекарственное средство
|
KR101992449B1
(ko)
|
2011-06-07 |
2019-06-24 |
젤레시스 엘엘씨 |
하이드로겔 생성 방법
|
EA201400172A1
(ru)
|
2011-07-29 |
2014-06-30 |
Грюненталь Гмбх |
Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
|
EA201400173A1
(ru)
|
2011-07-29 |
2014-06-30 |
Грюненталь Гмбх |
Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
|
BR112014008744A2
(pt)
|
2011-10-21 |
2017-04-18 |
Takeda Pharmaceuticals Co |
preparação de libertação prolongada, e, métodos para produzir uma preparação de liberação prolongada, e para prevenir e/ou retardar o início ou suprimir a progressão da doença de alzheimer
|
US20130143867A1
(en)
|
2011-12-02 |
2013-06-06 |
Sychroneuron Inc. |
Acamprosate formulations, methods of using the same, and combinations comprising the same
|
JP6117249B2
(ja)
|
2012-02-28 |
2017-04-19 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
|
WO2013147135A1
(ja)
*
|
2012-03-30 |
2013-10-03 |
アステラス製薬株式会社 |
放出制御医薬組成物
|
JP6282261B2
(ja)
|
2012-04-18 |
2018-02-21 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
不正使用防止および過量放出防止医薬剤形
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
ES2869870T3
(es)
*
|
2012-12-21 |
2021-10-26 |
Nestle Sa |
Dispositivo para producir espuma de leche
|
US8999393B1
(en)
|
2013-01-09 |
2015-04-07 |
Edgemont Pharmaceuticals Llc |
Sustained release formulations of lorazepam
|
AU2014215478B2
(en)
|
2013-02-05 |
2018-09-13 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
AR096439A1
(es)
|
2013-05-29 |
2015-12-30 |
Gruenenthal Gmbh |
Forma de dosificación resistente al uso indebido que contiene una o más partículas
|
AU2014273227B2
(en)
|
2013-05-29 |
2019-08-15 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing one or more particles
|
CA2914365C
(en)
|
2013-06-05 |
2022-03-15 |
Synchroneuron, Inc. |
Acamprosate formulations, methods of using the same, and combinations comprising the same
|
CA2917136C
(en)
|
2013-07-12 |
2022-05-31 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
|
JP6480936B2
(ja)
|
2013-11-26 |
2019-03-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
クライオミリングによる粉末状医薬組成物の調製
|
AU2015261060A1
(en)
|
2014-05-12 |
2016-11-03 |
Grunenthal Gmbh |
Tamper resistant immediate release capsule formulation comprising Tapentadol
|
EA201692388A1
(ru)
|
2014-05-26 |
2017-05-31 |
Грюненталь Гмбх |
Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
|
AU2015276889B2
(en)
|
2014-06-20 |
2019-04-18 |
Gelesis, Llc |
Methods for treating overweight or obesity
|
PL3215127T3
(pl)
|
2014-11-07 |
2021-05-17 |
Sublimity Therapeutics Limited |
Kompozycje zawierające cyklosporynę
|
RU2709361C2
(ru)
|
2015-01-29 |
2019-12-17 |
Джелезис Ллк |
Способ получения гидрогелей, характеризующихся сочетанием высокого модуля упругости и высокой абсорбционной способности
|
WO2016123482A2
(en)
|
2015-01-30 |
2016-08-04 |
Mylan, Inc. |
Sustained-release oral dosage forms for low aqueous solubility compounds
|
MX2017013637A
(es)
|
2015-04-24 |
2018-03-08 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes.
|
TWI722988B
(zh)
*
|
2015-06-05 |
2021-04-01 |
瑩碩生技醫藥股份有限公司 |
緩釋性醫藥組合物及其製備方法
|
CA2998259A1
(en)
|
2015-09-10 |
2017-03-16 |
Grunenthal Gmbh |
Protecting oral overdose with abuse deterrent immediate release formulations
|
US9687475B1
(en)
|
2016-03-24 |
2017-06-27 |
Ezra Pharma Llc |
Extended release pharmaceutical formulations with controlled impurity levels
|
US9675585B1
(en)
|
2016-03-24 |
2017-06-13 |
Ezra Pharma |
Extended release pharmaceutical formulations
|
CN105770866A
(zh)
*
|
2016-04-08 |
2016-07-20 |
王夕花 |
一种缓释型降糖药物组合物及其制备方法
|
US10543174B2
(en)
|
2016-04-25 |
2020-01-28 |
Synthon B.V. |
Modified release tablet composition comprising mirabegron
|
US20190307696A1
(en)
|
2016-04-25 |
2019-10-10 |
Synthon B.V. |
Tablets comprising mirabegron and solifenacin
|
CN109562069B
(zh)
|
2016-04-25 |
2022-06-03 |
吉莱斯公司 |
治疗便秘的方法
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
CA3078568A1
(en)
|
2017-10-12 |
2019-04-18 |
Synthon B.V. |
Modified release tablet composition comprising mirabegron
|
EP3292864A1
(en)
|
2017-10-12 |
2018-03-14 |
Synthon B.V. |
Modified release tablet composition comprising mirabegron
|
US10478399B2
(en)
|
2017-10-12 |
2019-11-19 |
Synthon B.V. |
Modified release tablet composition comprising mirabegron
|
WO2019076966A1
(en)
|
2017-10-17 |
2019-04-25 |
Synthon B.V. |
TABLETS COMPRISING TAMSULOSIN AND SOLIFENACIN
|
AR121207A1
(es)
*
|
2020-01-31 |
2022-04-27 |
Nippon Shinyaku Co Ltd |
Composición de liberación controlada
|
EP4255398A1
(en)
|
2020-12-01 |
2023-10-11 |
Adamed Pharma S.A. |
Orally-administered preparation containing solifenacin and tamsulosin
|
EP4037666B1
(en)
|
2020-12-08 |
2024-05-01 |
Ruminant Biotech Corp Limited |
Improvements to devices and methods for delivery of substances to animals
|